Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
VICI Properties
VICI
$28.9B
| $15.8M | 0.02% |
840,403
-745,438
| -47% | -$15.7M |
|
827
STAAR Surgical
STAA
$1.16B
| $15.8M | 0.02% |
494,011
-388,482
| -44% | -$15.1M |
|
|
GWPH
828
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $15.7M | 0.02% |
+161,058
| New | +$21.1M |
|
|
ACC
829
DELISTED
American Campus Communities, Inc.
ACC
| $15.7M | 0.02% |
378,863
+312,008
| +467% | +$12.9M |
|
830
Tetra Tech
TTEK
$9.42B
| $15.7M | 0.02% |
1,511,700
+447,515
| +42% | +$5.55M |
|
|
RCM
831
DELISTED
R1 RCM Inc. Common Stock
RCM
| $15.6M | 0.02% |
1,968,470
+1,160,264
| +144% | +$10M |
|
|
LADR
832
Ladder Capital
LADR
$1.26B
| $15.6M | 0.02% |
1,010,308
+284,287
| +39% | +$4.83M |
|
|
APLS
833
DELISTED
Apellis Pharmaceuticals
APLS
| $15.6M | 0.02% |
1,182,385
+75,276
| +7% | +$1.16M |
|
|
ALXN
834
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $15.6M | 0.02% |
160,000
-60,000
| -27% | -$7.09M |
|
835
Rollins
ROL
$17.5B
| $15.6M | 0.02% |
646,221
+428,533
| +197% | +$11.1M |
|
|
AMWD
836
DELISTED
American Woodmark
AMWD
| $15.5M | 0.02% |
279,263
+60,174
| +27% | +$3.83M |
|
837
AptarGroup
ATR
$8.57B
| $15.5M | 0.02% |
165,194
+64,550
| +64% | +$6.58M |
|
838
Red Rock Resorts
RRR
$3.53B
| $15.5M | 0.02% |
764,373
+359,237
| +89% | +$8.45M |
|
839
PUT
VanEck Oil Services ETF
OIH
$1.93B
| $15.5M | 0.02% |
+55,315
| New | +$21.9M |
|
840
SPS Commerce
SPSC
$2.9B
| $15.5M | 0.02% |
376,400
+163,138
| +76% | +$7.12M |
|
841
Stewart Information Services
STC
$2.12B
| $15.5M | 0.02% |
374,395
+63,972
| +21% | +$2.69M |
|
|
PBCT
842
DELISTED
People's United Financial Inc
PBCT
| $15.5M | 0.02% |
1,072,912
-564,691
| -34% | -$8.94M |
|
843
3M
MMM
$92.5B
| $15.5M | 0.02% |
97,158
+82,564
| +566% | +$13.7M |
|
|
BNFT
844
DELISTED
Benefitfocus, Inc.
BNFT
| $15.5M | 0.02% |
338,322
-485,693
| -59% | -$20.3M |
|
845
Rithm Capital
RITM
$5.68B
| $15.4M | 0.02% |
1,085,593
+390,863
| +56% | +$6.6M |
|
|
WW
846
DELISTED
WW International
WW
| $15.4M | 0.02% |
399,845
-640,531
| -62% | -$35.1M |
|
847
PUT
Adobe
ADBE
$109B
| $15.4M | 0.02% |
68,100
+67,300
| +8,413% | +$16.2M |
|
848
Graco
GGG
$12.7B
| $15.4M | 0.02% |
367,964
+84,606
| +30% | +$3.54M |
|
|
HBI
849
DELISTED
Hanesbrands
HBI
| $15.4M | 0.02% |
1,228,277
-1,199,819
| -49% | -$18.7M |
|
|
ISBC
850
DELISTED
Investors Bancorp, Inc.
ISBC
| $15.4M | 0.02% |
1,477,207
+638,328
| +76% | +$7.37M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.